Newsletter Archives

Showing 181 to 200 of 752 articles.

EBM Focus - Volume 15, Issue 40

COVID-19: 10 things you need to know NOW

EBM Focus - Volume 15, Issue 39

Convalescent plasma for COVID-19: Caveat emptor

EBM Focus - Volume 15, Issue 38

Putting together the autism puzzle: Still missing the corner piece

Resident Focus - Volume 15, Issue 11

In euthyroid patients with persistent symptoms of Hashimoto thyroiditis on thyroid replacement therapy, total thyroidectomy may improve general health and fatigue compared to medical management

EBM Focus - Volume 15, Issue 37

Swimming in pooled data: A prospective meta-analysis of steroids for COVID-19

EBM Focus - Volume 15, Issue 36

Getting a leg up on sciatica: does early physical therapy referral help?

EBM Focus - Volume 15, Issue 35

Hey dipstick! A new screening option for albuminuria in patients with diabetes

EBM Focus - Volume 15, Issue 34

Returning to an old rhythm for atrial fibrillation?

Resident Focus - Volume 15, Issue 10

In patients with heart failure with reduced ejection fraction, dapagliflozin reduces risk of composite of worsening heart failure and cardiovascular death in both patients with or without diabetes

EBM Focus - Volume 15, Issue 33

Remdesivir for COVID: Remain skeptical

EBM Focus - Volume 15, Issue 32

Hot off the press: Heat and air pollution linked to poor pregnancy outcomes

EBM Focus - Volume 15, Issue 31

Collateral damage of COVID-19 pandemic stress

Resident Focus - Volume 15, Issue 9

Addition of fenofibrate to statins may reduce composite cardiovascular events in adults with metabolic syndrome

EBM Focus - Volume 15, Issue 30

Bold new recommendations for cervical cancer screening

EBM Focus - Volume 15, Issue 29

Narrow external validation of the Hematuria Risk Index

EBM Focus - Volume 15, Issue 28

Hydroxychloroquine still of unproven benefit for COVID-19

EBM Focus - Volume 15, Issue 27

Headline or hypothesis? ACE inhibitors/ARBs and decreased colon cancer risk

Resident Focus - Volume 15, Issue 8

Acetazolamide 62.5 mg twice daily may be as effective as standard dose (125 mg twice daily) for reducing the risk of acute mountain sickness

EBM Focus - Volume 15, Issue 26

Five things you should know about COVID-19 antibody testing

EBM Focus - Volume 15, Issue 25

Azithromycin and propensity for death: side effect or sicker patients?